Achieve Life Sciences Inc (ACHV) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
Achieve Life Sciences, Inc. - Common Shares (ACHV)
Last achieve life sciences, inc. - common shares earnings: 3/13 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.achievelifesciences.com
Company Research
Source: Yahoo! Finance
Debt Refinancing Agreement: Up to $20 million in availability with SVB. Operating Expenses: Increased due to ORCA-OL trial enrollment. Release Date: November 07, 2024 Warning! GuruFocus has detected 3 Warning Signs with ACHV. For the complete transcript of the earnings call, please refer to the full earnings call transcript Achieve Life Sciences Inc ( NASDAQ:ACHV ) received FDA breakthrough therapy designation for Cytisinicline for vaping cessation, enhancing regulatory support. The company completed enrollment for the ORCA-OL safety trial ahead of schedule, demonstrating efficient trial management. Cytisinicline is positioned to be the first new prescription smoking cessation drug in nearly 20 years, with promising efficacy and tolerability. Achieve Life Sciences Inc ( NASDAQ:ACHV ) has a strategic plan for a digital-first commercial launch, leveraging data-driven approaches to target primary care physicians and patients effectively. The company successfully refina
Show less
Read more
Impact Snapshot
Event Time:
ACHV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACHV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACHV alerts
High impacting Achieve Life Sciences, Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
ACHV
News
- Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate UpdateGlobeNewswire
- Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024GlobeNewswire
- Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public MeetingGlobeNewswire
- Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of CytisiniclineGlobeNewswire
ACHV
Earnings
- 11/7/24 - Miss
ACHV
Sec Filings
- 11/12/24 - Form SC
- 11/7/24 - Form S-3
- 11/7/24 - Form POS
- ACHV's page on the SEC website